Australia markets close in 3 hours 18 minutes

Aptose Biosciences Inc. (APS.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
1.6800+0.0400 (+2.44%)
At close: 01:16PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 27.30M
Enterprise value 16.04M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.33
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.42

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3-82.77%
S&P500 52-week change 326.27%
52-week high 310.3500
52-week low 31.5900
50-day moving average 31.9190
200-day moving average 33.3259

Share statistics

Avg vol (3-month) 39.4k
Avg vol (10-day) 35.46k
Shares outstanding 516.25M
Implied shares outstanding 616.25M
Float 812.53M
% held by insiders 119.07%
% held by institutions 18.15%
Shares short (30 Apr 2024) 418.34k
Short ratio (30 Apr 2024) 41
Short % of float (30 Apr 2024) 40.14%
Short % of shares outstanding (30 Apr 2024) 40.11%
Shares short (prior month 28 Mar 2024) 46.88k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 306 June 2023

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-102.23%
Return on equity (ttm)-293.95%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -52.27M
Net income avi to common (ttm)-51.21M
Diluted EPS (ttm)-10.4100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.25M
Total cash per share (mrq)0.59
Total debt (mrq)1.01M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.78
Book value per share (mrq)-0.37

Cash flow statement

Operating cash flow (ttm)-44.59M
Levered free cash flow (ttm)-25.82M